Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Skip to article
Collection contents

Lupus nephritis · For patients

Lupus Nephritis: Patient Essentials

Start here: what kidney involvement in lupus means, why tests and biopsy matter, how treatment is chosen, and when to seek help.

Open access
On this page

A diagnosis of lupus nephritis brings unfamiliar words, laboratory results and often several medicines at once. You do not need to master everything on day one. Start with three questions: What is happening in my kidneys? What is the treatment trying to change? How will we know whether it is working?

What lupus nephritis means

Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, or SLE. An immune response that should protect the body instead injures its own tissues. In the kidneys, this often affects the tiny filtering structures called glomeruli. Protein or blood cells can leak into urine, and kidney function can decline. Other kidney structures may also be affected.

The diagnosis does not automatically mean kidney failure or dialysis. Treatment aims to control inflammation and preserve kidney function. Your outlook depends on several factors, including the type and amount of injury and the response to treatment. Read: Understanding lupus nephritis.

Why tests matter when you feel well

Early kidney inflammation may cause no pain or obvious symptoms. Swelling, foamy urine and high blood pressure can occur, but none tells the whole story. Foam alone does not diagnose nephritis. Feeling well does not rule it out.

Urine tests look for protein, blood and other clues. A urine protein-to-creatinine ratio estimates protein loss. Blood creatinine helps estimate filtration, reported as eGFR. Blood albumin, blood counts and lupus markers add context. A normal creatinine does not exclude important inflammation; an abnormal lupus antibody result alone does not prove that the kidneys are flaring.

The pattern over time matters more than one isolated number. Ask which results your team is following and when to repeat them. Why monitoring matters · Understanding urine and blood tests.

What a biopsy can explain

A kidney biopsy examines a small tissue sample. It can identify the pattern of injury, distinguish active inflammation from scarring, and reveal another explanation for abnormal tests. Your team weighs its value against bleeding risk and other individual concerns.

The biopsy report may describe a class from I to VI. These are tissue patterns, not six inevitable stages through which everyone progresses. Some patterns occur together. The report also describes activity and chronic damage: inflammation may respond to treatment, while established scarring generally does not reverse with stronger immune suppression. Treatment decisions use the whole report, your tests and your circumstances.

Preparing for a kidney biopsy · Making sense of the biopsy report.

Why treatment may involve several medicines

The plan usually addresses two connected jobs: controlling immune inflammation and protecting kidney function. Rheumatology and nephrology often work together. Treatment is chosen according to the biopsy, kidney function, protein loss, other lupus problems, infection risk, reproductive plans and your preferences.

Hydroxychloroquine is commonly recommended unless there is a reason it cannot be used. Active nephritis may require glucocorticoids and other immune treatments, such as mycophenolate or cyclophosphamide. Selected combinations can include belimumab, a calcineurin inhibitor such as voclosporin, or obinutuzumab. These are examples, not an interchangeable menu or a prescription for everyone; approvals and availability differ between countries.

Early treatment brings inflammation under control; longer-term treatment helps prevent its return. Steroids are reduced as the situation allows. Do not stop them suddenly or change other medicines because a result improves. Tell your team about side effects, cost or missed doses: these are problems to solve together. How treatment is planned · What each medicine is for.

Safety is part of treatment

Ask for a written monitoring plan: blood and urine tests, infection precautions, vaccinations, and any medicine needed to prevent particular infections. Eye monitoring matters with hydroxychloroquine. Bone health and other risks deserve attention when steroids are used. The details depend on your medicines and medical history.

Report new symptoms rather than assuming they are lupus or a harmless drug effect. Before adding a supplement or over-the-counter product, check it with your clinician or pharmacist. Treatment safety.

How you and your team judge progress

Doctors follow protein loss, kidney function, urine findings, blood pressure and your overall condition. Improvement often takes months. A falling protein level is encouraging, but there is no single test that proves all inflammation has disappeared. Persistent protein can reflect ongoing inflammation, residual injury or both.

Ask for your next treatment target and review date. Results that worsen, stall or do not fit the expected pattern need reassessment; the answer is not always simply more medication. Remission means good disease control, not permission to abandon monitoring. Response and remission · When results worsen.

Everyday kidney protection

Take prescribed blood-pressure medicines, follow your agreed salt intake and avoid smoking. Food and fluid advice should fit your kidney function, blood tests and swelling. Not everyone needs potassium restriction or extra water. Avoid high-protein supplements unless your kidney team approves them.

Ibuprofen, naproxen and similar anti-inflammatory painkillers can be unsafe for vulnerable kidneys, particularly during dehydration. Ask what you can use instead. Tell your team if vomiting or diarrhea prevents normal drinking or taking medicines. Daily kidney protection.

Pregnancy and the longer view

Discuss pregnancy before trying to conceive. The safest plan usually includes nephritis that has been inactive for at least six months and medicines compatible with pregnancy. Some treatments can harm a developing baby; changing them requires a plan that also protects you. If pregnancy occurs unexpectedly, contact your team promptly. Pregnancy and reproductive planning.

If chronic kidney disease remains, care continues even when lupus is quiet. Advanced kidney disease may require discussion of dialysis or transplantation, but these are not inevitable outcomes. Living with chronic kidney damage.

Mycophenolate (CellCept/Myfortic) and cyclophosphamide can harm a developing baby. Reliable, medication-specific contraception and a planned treatment change are essential before pregnancy. ACE inhibitors and ARBs also carry fetal risk. Do not improvise a stopping interval: the pregnancy chapter explains the precautions.

When to seek urgent help

Get emergency help now for severe breathlessness, chest pain, new confusion, a seizure, or sudden weakness or trouble speaking. Do not wait for the next lupus appointment.

Contact your care team promptly, usually the same day, for markedly reduced urine, rapidly increasing swelling, or fever or signs of infection while taking immune-suppressing treatment. Follow any more specific emergency instructions your team has given you. If you are severely unwell or cannot reach help promptly, use urgent or emergency care.

Bring these questions to your next visit

  • What did my biopsy and recent tests show?
  • What is each medicine doing, and what monitoring does it need?
  • What result are we aiming for next, and by when?
  • Whom should I contact about worsening symptoms or missed treatment?

Bring your medicine list and recent results. Prepare for your appointment.

Sources and further reading

  1. NIDDK — Lupus & Kidney Disease
  2. NIDDK — Kidney Biopsy
  3. KDIGO — Lupus Nephritis Guideline (2024)
  4. American College of Rheumatology — Lupus Nephritis Guideline (published 2025)
  5. FDA — Gazyva (obinutuzumab), prescribing information (2026)
  6. NIDDK — Keeping Kidneys Safe: Smart Choices about Medicines
  7. NIDDK — Healthy Eating for Adults with Chronic Kidney Disease
  8. American College of Rheumatology — Pregnancy and Rheumatic Disease
  9. Genentech — CellCept: US Prescribing Information
  10. DailyMed — Cyclophosphamide Tablets: US Prescribing Information

Rheumatology in Perspective · by Olga Goodman, MD
A RheumaView publication

Evidence checked: 17 October 2026

Educational information. Individual decisions belong with the treating clinical team.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: lupus nephritis